Health and Healthcare
Major Pharma Short Interest Takes Another Giant Leap Forward
Published:
Last Updated:
The short interest data have been released for the December 15 settlement date. Pharmaceutical companies are usually involved in a lengthy process in getting their drug candidates to market through clinical trials. There is a fair amount of risk involved, should a study come back negative or a candidate not be approved. Conversely, if a drug is approved or passes a clinical trial, there can be big upside.
The December short interest data have been compared with the previous figures, and for most of the selected pharmaceutical stocks short interest was up.
Pfizer Inc. (NYSE: PFE) saw its short interest jump to 85.66 million shares from the previous 65.52 million. Last February, short interest spiked incredibly, and since that time it has slowly backed off. The highest short interest reading on the year was 207.4 million. Shares of Pfizer closed Thursday at $32.62, within a 52-week trading range of $28.47 to $36.46.
Merck & Co. Inc. (NYSE: MRK) saw short interest increase to 25.61 million shares from 24.81 million in the previous period. Merck shares closed Thursday at $52.85, in a 52-week trading range of $45.69 to $63.62.
Teva Pharmaceutical Industries Ltd. (NYSE: TEVA) short interest more than doubled to 16.82 million shares. The previous level was 7.19 million. The current level is the highest in the past 52 weeks. Shares of Teva closed Thursday at $66.32, in a 52-week trading range of $54.17 to $72.31.
Bristol-Myers Squibb Co. (NYSE: BMY) saw its short interest increase slightly to 23.57 million shares from the previous reading of 23.30 million. Bristol-Myers shares closed Thursday at $68.97, within a 52-week range of $51.82 to $70.87.
AbbVie Inc. (NYSE: ABBV) short interest increased to 21.09 million shares from the previous level of 20.23 million. Short interest has backed way off its highest level year to date in May. Shares of AbbVie closed Thursday at $58.46, in a 52-week trading range of $45.45 to $71.60.
Want to Retire Early? Start Here (Sponsor)
Want retirement to come a few years earlier than you’d planned? Or are you ready to retire now, but want an extra set of eyes on your finances?
Now you can speak with up to 3 financial experts in your area for FREE. By simply clicking here you can begin to match with financial professionals who can help you build your plan to retire early. And the best part? The first conversation with them is free.
Click here to match with up to 3 financial pros who would be excited to help you make financial decisions.
Have questions about retirement or personal finance? Email us at [email protected]!
By emailing your questions to 24/7 Wall St., you agree to have them published anonymously on a673b.bigscoots-temp.com.
By submitting your story, you understand and agree that we may use your story, or versions of it, in all media and platforms, including via third parties.
Thank you for reading! Have some feedback for us?
Contact the 24/7 Wall St. editorial team.
Latest from 24/7
